Resignation of Mr. Prakash B. Shah with Disclosure as per BSE query
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Prakash Bhoorchand Shah (DIN: 01136800) resigned as a Director of Bacil Pharma Ltd effective 22nd July 2025, citing personal pre-occupation. The company filed a revised intimation with BSE after the exchange pointed out that the original disclosure did not include the names of other listed entities where the resigning director holds directorships. Mr. Shah also serves as a Non-Executive Director on Sanmitra Commercial Limited, where he sits on the Audit, Nomination & Remuneration, and Stakeholders Relationship Committees. The revised filing now includes his resignation letter, the required confirmation that there are no other material reasons, and details of his other directorships.
This appears to be a routine director exit driven by personal reasons, with the BSE query being a procedural correction rather than a substantive governance issue. Likely little to no impact on shareholders or the stock price, though investors may note the continued thinning of the small-cap company's board.